VVUS

3 Pharmaceutical Stocks to Sell Now

This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

A New Rice Diet Company is Set to Launch Next Month

John Aycoth, a former Washington, D.C., lobbyist, is set to launch his Rice House Healthcare Program next month. More 

3 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of three Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More